Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Rotherham, Lia S ^a,b   Maserumule, Charlotte ^a,c   Dheda, Keertan ^c   Theron, Jacques ^b   Khati, Makobetsa ^a,c  

^a DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; SINGLE STRANDED DNA APTAMER; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISSOCIATION CONSTANT; HUMAN; NONHUMAN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS;

ANTIGENS, BACTERIAL; APTAMERS, NUCLEOTIDE; BACTERIAL PROTEINS; BINDING, COMPETITIVE; DNA, SINGLE-STRANDED; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; SELEX APTAMER TECHNIQUE; SPUTUM; SUBSTRATE SPECIFICITY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84867136851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046862     Document Type: Article

References (54)

1. WHO (2011) WHO report 2011: Global Tuberculosis control. World Health Organization.
2. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375: 1830-1843.
3. Jarand J, Shean K, O'Donnell M, Loveday M, Kvasnovsky C, et al. (2010) Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa. Trop Med Int Health 15: 1179-1184.
4. O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, et al. (2010) High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med 153: 516-522.
5. Alderson MR, Bement T, Day CH, Zhu L, Molesh D, et al. (2000) Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. J Exp Med 191: 551-560.
6. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, et al. (2006) Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6: 570-581.
7. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6: 664-674.
8. Andersen P, Munk ME, Pollock JM, Doherty TM, (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
9. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, et al. (2010) Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 5: e9848.
10. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4: e4689.
11. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
12. Arend SM, Andersen P, van Meijgaarden KE, Skjot RL, Subronto YW, et al. (2000) Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 181: 1850-1854.
13. Brodin P, de Jonge MI, Majlessi L, Leclerc C, Nilges M, et al. (2005) Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem 280: 33953-33959.
14. Dillon DC, Alderson MR, Day CH, Bement T, Campos-Neto A, et al. (2000) Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 38: 3285-3290.
15. Kulshrestha A, Gupta A, Verma N, Sharma SK, Tyagi AK, et al. (2005) Expression and purification of recombinant antigens of Mycobacterium tuberculosis for application in serodiagnosis. Protein Expr Purif 44: 75-85.
16. Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, et al. (2005) Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. Embo J 24: 2491-2498.
17. Renshaw PS, Panagiotidou P, Whelan A, Gordon SV, Hewinson RG, et al. (2002) Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 277: 21598-21603.
18. Andersen P, (1994) The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology 191: 537-547.
19. Skjot RL, Oettinger T, Rosenkrands I, Ravn P, Brock I, et al. (2000) Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 68: 214-220.
20. Feng TT, Shou CM, Shen L, Qian Y, Wu ZG, et al. (2011) Novel monoclonal antibodies to ESAT-6 and CFP-10 antigens for ELISA-based diagnosis of pleural tuberculosis. Int J Tuberc Lung Dis 15: 804-810.
21. Mabey D, Peeling RW, Ustianowski A, Perkins MD, (2004) Diagnostics for the developing world. Nat Rev Microbiol 2: 231-240.
22. Ellington AD, Szostak JW, (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
23. Robertson DL, Joyce GF, (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344: 467-468.
24. Tuerk C, Gold L, (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
25. Low SY, Hill JE, Peccia J, (2009) DNA aptamers bind specifically and selectively to (1->3)-beta-D-glucans. Biochem Biophys Res Commun 378: 701-705.
26. Lee JF, Stovall GM, Ellington AD, (2006) Aptamer therapeutics advance. Curr Opin Chem Biol 10: 282-289.
27. Liu J, Lu Y, (2005) Fast colorimetric sensing of adenosine and cocaine based on a general sensor design involving aptamers and nanoparticles. Angew Chem Int Ed Engl 45: 90-94.
28. Liu J, Lu Y, (2006) Preparation of aptamer-linked gold nanoparticle purple aggregates for colorimetric sensing of analytes. Nat Protoc 1: 246-252.
29. Wang JY, Chou CH, Lee LN, Hsu HL, Jan IS, et al. (2007) Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis 13: 553-558.
30. Wang L, Liu X, Hu X, Song S, Fan C (2006) Unmodified gold nanoparticles as a colorimetric probe for potassium DNA aptamers. Chem Commun (Camb): 3780-3782.
31. Wei H, Li B, Li J, Wang E, Dong S (2007) Simple and sensitive aptamer-based colorimetric sensing of protein using unmodified gold nanoparticle probes. Chem Commun (Camb): 3735-3737.
32. Shum KT, Lui EL, Wong SC, Yeung P, Sam L, et al. (2011) Aptamer-Mediated Inhibition of Mycobacterium tuberculosis Polyphosphate Kinase 2. Biochemistry 50: 3261-3271.
33. Chen F, Zhou J, Luo F, Mohammed AB, Zhang XL, (2007) Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun 357: 743-748.
34. Qin L, Zheng R, Ma Z, Feng Y, Liu Z, et al. (2009) The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis. Clin Chem Lab Med 47: 405-411.
35. Jhaveri SD, Ellington AD (2001) In vitro selection of RNA aptamers to a protein target by filter immobilization. Curr Protoc Nucleic Acid Chem Chapter 9: Unit 9 3.
36. Avci-Adali M, Paul A, Wilhelm N, Ziemer G, Wendel HP, (2010) Upgrading SELEX technology by using lambda exonuclease digestion for single-stranded DNA generation. Molecules 15: 1-11.
37. Drolet DW, Moon-McDermott L, Romig TS, (1996) An enzyme-linked oligonucleotide assay. Nat Biotechnol 14: 1021-1025.
38. Chaudhary VK, Kulshreshta A, Gupta G, Verma N, Kumari S, et al. (2005) Expression and purification of recombinant 38-kDa and Mtb81 antigens of Mycobacterium tuberculosis for application in serodiagnosis. Protein Expr Purif 40: 169-176.
39. Adachi H, Ishiguro A, Hamada M, Sakota E, Asai K, et al. (2011) Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F. Biochimie 93: 1081-1088.
40. Huang DB, Vu D, Cassiday LA, Zimmerman JM, Maher LJ, 3rd, et al (2003) Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. Proc Natl Acad Sci U S A 100: 9268-9273.
41. Jaeger J, Restle T, Steitz TA, (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. Embo J 17: 4535-4542.
42. Kettenberger H, Eisenfuhr A, Brueckner F, Theis M, Famulok M, et al. (2006) Structure of an RNA polymerase II-RNA inhibitor complex elucidates transcription regulation by noncoding RNAs. Nat Struct Mol Biol 13: 44-48.
43. Storz G, Altuvia S, Wassarman KM, (2005) An abundance of RNA regulators. Annu Rev Biochem 74: 199-217.
44. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, et al. (2011) Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184: 957-963.
45. Converse SE, Cox JS, (2005) A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis. J Bacteriol 187: 1238-1245.
46. Maciag A, Piazza A, Riccardi G, Milano A, (2009) Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis. BMC Microbiol 9: 48.
47. Gey van Pittius NC, Gamieldien J, Hide W, Brown GD, Siezen RJ, et al. (2001) The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2: RESEARCH0044.
48. Pallen M, Chaudhuri R, Khan A, (2002) Bacterial FHA domains: neglected players in the phospho-threonine signalling game? Trends Microbiol 10: 556-563.
49. Gomez JE, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84: 29-44.
50. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, et al. (2010) Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 16: 262-270.
51. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, et al. (2012) Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J.
52. Yang CJ, Jockusch S, Vicens M, Turro NJ, Tan W, (2005) Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A 102: 17278-17283.
53. Laurenson S, Pett MR, Hoppe-Seyler K, Denk C, Hoppe-Seyler F, et al. (2011) Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts. Anal Biochem 410: 161-170.
54. Shangguan D, Tang Z, Mallikaratchy P, Xiao Z, Tan W, (2007) Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem 8: 603-606.